Join to view full profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000
Fax+1 206-520-5620
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Melinda Biernacki, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Rhode Island. She is affiliated with Fred Hutch Cancer Center.
Education & Training
University of WashingtonResidency, Gastroenterology, 2021 - 2027
University of WashingtonFellowship, Hematology and Medical Oncology, 2013 - 2016
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine/Pediatrics, 2009 - 2013
Uconn School Of MedicineClass of 2009
Certifications & Licensure
WA State Medical License 2013 - 2027
RI State Medical License 2009 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsClinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies.Melinda A Biernacki, Marie Bleakley
Expert Review of Hematology. 2025-01-01 - Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG report.Jasmine Naru, Megan Othus, ChenWei Lin, Melinda A Biernacki, Marie Bleakley
Ejhaem. 2024-12-01 - 8 citationsCMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation.Danniel Zamora, Hu Xie, Alicja Sadowska-Klasa, Eleftheria Kampouri, Melinda A Biernacki
Blood Advances. 2024-09-10
Press Mentions
Fred Hutch at ASH: Expanding CAR-T Access, AML Treatment Strategies, Climate and Cancer — and ASH Lifetime Achievement AwardDecember 3rd, 2025
Seattle Cancer Care Alliance to Present New Research at 62nd Annual Meeting of the American Society of HematologyDecember 4th, 2020










